Halozyme Therapeutics (HALO) Research & Development (2010 - 2026)
Halozyme Therapeutics (HALO) reported Research & Development of $27.66 million for Q2 2026, up 57.7% from $17.54 million a year earlier and up 8.2% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Research & Development (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Halozyme Therapeutics' Research & Development came in at $102.37 million, up 43.7% year-over-year; for FY2025, it came in at $81.49 million, up 3.1% from FY2024.
- Research & Development has increased for five consecutive years, with a five-year compound annual growth rate of 18.9% (FY2020 to FY2025).
- By year, Research & Development came in at $79.05 million in FY2024 (+3.5%), $76.36 million in FY2023 (+14.6%), $66.61 million in FY2022 (+86.7%) and $35.67 million in FY2021 (+4.2%).
- Five-year quarterly Research & Development spans a low of $8.49 million in Q3 2021 and a high of $31.9 million in Q4 2025.
- Year over year, Research & Development has now increased in each of the last three quarters, with growth averaging 17.9% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was Q4 2022 (growth of 123.2%); the low point was Q1 2025 (a decline of 22.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $25.56 million (Q1 2026), $31.9 million (Q4 2025) and $17.25 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Halozyme Therapeutics | 12.72 Bn | 11.33 Bn | 401.83 Mn | 27.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.66 Mn |
| Mar 31, 2026 | 25.56 Mn |
| Dec 31, 2025 | 31.90 Mn |
| Sep 30, 2025 | 17.25 Mn |
| Jun 30, 2025 | 17.54 Mn |
| Mar 31, 2025 | 14.80 Mn |
| Dec 31, 2024 | 20.44 Mn |
| Sep 30, 2024 | 18.46 Mn |
| Jun 30, 2024 | 21.04 Mn |
| Mar 31, 2024 | 19.11 Mn |
| Dec 31, 2023 | 21.34 Mn |
| Sep 30, 2023 | 17.32 Mn |
| Jun 30, 2023 | 19.73 Mn |
| Mar 31, 2023 | 17.98 Mn |
| Dec 31, 2022 | 22.57 Mn |
| Sep 30, 2022 | 16.71 Mn |
| Jun 30, 2022 | 15.48 Mn |
| Mar 31, 2022 | 11.85 Mn |
| Dec 31, 2021 | 10.11 Mn |
| Sep 30, 2021 | 8.49 Mn |
API Access
Halozyme Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();